Minthon L - Search Results

1

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.

Olsson A, Höglund K, Sjögren M, Andreasen N, Minthon L, Lannfelt L, Buerger K, Möller HJ, Hampel H, Davidsson P, Blennow K. Olsson A, et al. Among authors: minthon l. Exp Neurol. 2003 Sep;183(1):74-80. doi: 10.1016/s0014-4886(03)00027-x. Exp Neurol. 2003. PMID: 12957490 Clinical Trial.

2

Longitudinal stability of CSF biomarkers in Alzheimer's disease.

Blennow K, Zetterberg H, Minthon L, Lannfelt L, Strid S, Annas P, Basun H, Andreasen N. Blennow K, et al. Among authors: minthon l. Neurosci Lett. 2007 May 23;419(1):18-22. doi: 10.1016/j.neulet.2007.03.064. Epub 2007 Apr 6. Neurosci Lett. 2007. PMID: 17482358

3

Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease.

Rosén C, Andreasson U, Mattsson N, Marcusson J, Minthon L, Andreasen N, Blennow K, Zetterberg H. Rosén C, et al. Among authors: minthon l. Neuromolecular Med. 2012 Mar;14(1):65-73. doi: 10.1007/s12017-012-8171-4. Epub 2012 Feb 18. Neuromolecular Med. 2012. PMID: 22350541

4

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease.

Hölttä M, Hansson O, Andreasson U, Hertze J, Minthon L, Nägga K, Andreasen N, Zetterberg H, Blennow K. Hölttä M, et al. Among authors: minthon l. PLoS One. 2013 Jun 14;8(6):e66381. doi: 10.1371/journal.pone.0066381. Print 2013. PLoS One. 2013. PMID: 23799095 Free PMC article.

5

Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease.

Johansson A, Zetterberg H, Hampel H, Buerger K, Prince JA, Minthon L, Wahlund LO, Blennow K. Johansson A, et al. Among authors: minthon l. Dement Geriatr Cogn Disord. 2005;20(6):367-74. doi: 10.1159/000088634. Epub 2005 Sep 29. Dement Geriatr Cogn Disord. 2005. PMID: 16192727

6

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K. Andreasen N, et al. Among authors: minthon l. Arch Neurol. 1999 Jun;56(6):673-80. doi: 10.1001/archneur.56.6.673. Arch Neurol. 1999. PMID: 10369305

7

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD.

Sjögren M, Rosengren L, Minthon L, Davidsson P, Blennow K, Wallin A. Sjögren M, et al. Among authors: minthon l. Neurology. 2000 May 23;54(10):1960-4. doi: 10.1212/wnl.54.10.1960. Neurology. 2000. PMID: 10822437

8

Measurement of apolipoprotein E (apoE) in cerebrospinal fluid.

Hesse C, Larsson H, Fredman P, Minthon L, Andreasen N, Davidsson P, Blennow K. Hesse C, et al. Among authors: minthon l. Neurochem Res. 2000 Apr;25(4):511-7. doi: 10.1023/a:1007516210548. Neurochem Res. 2000. PMID: 10823584

9

TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD.

Tarkowski E, Liljeroth AM, Nilsson A, Ricksten A, Davidsson P, Minthon L, Blennow K. Tarkowski E, et al. Among authors: minthon l. Neurology. 2000 Jun 13;54(11):2077-81. doi: 10.1212/wnl.54.11.2077. Neurology. 2000. PMID: 10851366

10

Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease.

Davidsson P, Blennow K, Andreasen N, Eriksson B, Minthon L, Hesse C. Davidsson P, et al. Among authors: minthon l. Neurosci Lett. 2001 Mar 16;300(3):157-60. doi: 10.1016/s0304-3940(01)01586-5. Neurosci Lett. 2001. PMID: 11226635 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters